Ciphergen Shares Slide 11 Percent After It Exchanged Debt, Cash | GenomeWeb
NEW YORK (GenomeWeb News) — Shares in Ciphergen were down 10.91 percent, or $.12, at $.98 in mid-afternoon trading today after the company said it finished exchanging $27.5 million worth of outstanding debt for a new series of notes worth $16.5 million, plus cash.

Ciphergen said it finished the exchange of 4.5-percent senior notes due 2008 for a new series of 7-percent convertible senior notes due 2011, together with $11 million in cash.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.